# Temozolomide as Maintenance Therapy in Small Cell Lung Cancer

> **NCT01900951** · PHASE2 · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Carcinoma, Small Cell

## Interventions

- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT01900951
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2016-02
- **Final completion:** 2016-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2016-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01900951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01900951, "Temozolomide as Maintenance Therapy in Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01900951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*